跳至主要内容
临床试验/ISRCTN99883695
ISRCTN99883695进行中(未招募)2 期

ow-dose atropine eye drops to reduce progression of myopia in children: a multi-centre placebo-controlled randomised trial in the United Kingdom

Belfast Health and Social Care Trust0 个研究点目标入组 289 人开始时间: 2018年10月25日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
289

研究概览

简要总结

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31653669/ (added 05/05/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 6-12 years (at the time of consenting)
  • 2. Myopia of -0.5D or greater (spherical equivalent refractive error) in both eyes
  • 3. Best-corrected distance visual acuity (BCDVA) 0.20 logMAR or better in both eyes

排除标准

  • 1. Children with other ocular morbidities
  • 2. Myopia of -10D or greater in either eye
  • 3. Astigmatism of 2D or higher in either eye
  • 4. Amblyopia
  • 5. Significant health problems that can compromise the ability to attend research visits or complete the trial
  • 6. Other factors that may compromise the ability to attend the research appointments
  • 7. Parents or children with poor understanding of the English language
  • 8. Children enrolled in other interventional trials
  • 9. Allergy or hypersensitivity to atropine or excipients

研究者

相似试验

ow-dose atropine eye drops to reduce progression of... | 临床试验